First Midwest Bank Trust Division’s Galmed Pharmaceuticals GLMD Stock Holding History

First Midwest Bank Trust Division’s Portfolio GLMD Stock Details GLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-114	Closed	-$788K	–	366
2019 Q3	$788K	Hold	114	–	–	0.11%	194
2019 Q2	$1.21M	Sell	114 -10	-8%	-$103K	0.17%	143
2019 Q1	$1.46M	Sell	124 -25	-17%	-$291K	0.2%	131
2018 Q4	$1.47M	Buy	149 +132	+776%	+$1.84M	0.22%	119
2018 Q3	$323K	Buy	17 +1	+6%	+$18.7K	0.04%	347
2018 Q2	$282K	Buy	+16	New	+$185K	0.04%	375

Other funds holding GLMD

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Ibex Investors Denver, Colorado $194M AUM 23.58% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

PAWC

P.A.W. Capital Greenwich, Connecticut $131M AUM 35.16% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

RCG

Rock Creek Group Washington, District of Columbia $994M AUM 11.29% 1-Year Est. Return

First Midwest Bank Trust Division's GLMD Position: Q4 2019 in Review

First Midwest Bank Trust Division sold out of Galmed Pharmaceuticals (GLMD) in Q4 2019, closing a stake of 114 shares — an estimated $788K sold.

First Midwest Bank Trust Division first reported a position in GLMD in Q2 2018 and held it in 6 quarters. The position peaked at $1.47M in Q4 2018. 28 funds tracked by Wall St. Rank hold GLMD as of Q4 2019.

First Midwest Bank Trust Division reported no remaining Galmed Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
First Midwest Bank Trust Division sold 114 Galmed Pharmaceuticals shares in Q4 2019, an estimated $788K.
First Midwest Bank Trust Division first reported a position in Galmed Pharmaceuticals in Q2 2018 and held it in 6 quarters.
First Midwest Bank Trust Division's Galmed Pharmaceuticals position peaked at $1.47M in Q4 2018.
28 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q4 2019.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2019, filed 23 Jan 2020.